Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Kelun Biotech logo — Advancing the frontier of medical innovation through groundb...

Kelun Biotech

Advancing the frontier of medical innovation through groundbreaking research and development of novel therapeutics.

Founded 2016 Post-IPO Equity Total: $1.25B Biopharma, Biotechnology

General Information

Company Name Kelun Biotech
Founded Year 2016
Industries Biopharma, Biotechnology
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Kelun Biotech. To contact Kelun Biotech, visit kelun-biotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Kelun Biotech

Kelun Biotech is a biopharmaceutical company founded in 2016 and specializes in the research and development, production, and sales of innovative drugs in the Biopharma and Biotechnology sectors. The company's slogan, "Advancing the frontier of medical innovation through groundbreaking research and development of novel therapeutics," reflects its commitment to pushing the boundaries of medical innovation. In its most recent funding round, Kelun Biotech secured a noteworthy HKD541.40M in post-IPO equity investment on 08 May 2024. The investment came from Sichuan Kelun Pharmaceutical. Kelun Biotech's dedication to pioneering medical solutions positions it as a key player in advancing the future of healthcare.

Taxonomy: biopharmaceutical, medical innovation, therapeutics, novel drugs, biotech company, production, sales, innovative drugs

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity HKD541.40M 1
Sichuan Kelun Pharmaceutical
08 May 2024
Series B $200.00M 6
IDG Capital Sherpa Capital China Cinda Asset Management
IDG Capital, Sherpa Capital +4
30 Dec 2022
Series A CNY512.00M 3
IDG Capital Hillhouse Investment
IDG Capital, Hillhouse Investment +1
24 Mar 2021

Kelun Biotech Alternatives & Competitors

View All Alternatives
Kelun Biotech vs
Yuanyin Bio
Yuanyin Bio

Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clinical needs...

Series A
Biopharma, Biotechnology
Kelun Biotech vs
HilleVax
HilleVax United States

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel va...

Post-IPO Equity
76 employees
Biopharma, Biotechnology
Kelun Biotech vs
Myogen
Myogen

Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs.

Series D
Biopharma, Biotechnology
View all alternatives

FAQ About Kelun Biotech

Advancing the frontier of medical innovation through groundbreaking research and development of novel therapeutics.
Kelun Biotech was founded in 2016.
Kelun Biotech operates in Biopharma and Biotechnology. Its work centres on biopharmaceutical, medical innovation, therapeutics and novel drugs.
Kelun Biotech has completed 3 funding rounds, raising a total of $1.25B. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Kelun Biotech include Yuanyin Bio, HilleVax, Myogen, Zensun (Shanghai) Sci & Tech Co., Armetheon. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kelun Biotech and Yuanyin Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Kelun Biotech, https://bouncewatch.com/company/kelun-biotech, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes